论文部分内容阅读
目的:探讨病理诊断在乳腺癌保乳法治疗选择应用中的价值。方法:回顾性分析2012年6月~2013年6月期间本院收治的25例采取手术治疗乳腺癌患者的临床资料,分析保乳法手术的具体操作方法,总结病理诊断在其中的应用价值。结果:25例乳腺癌患者中,病理诊断为浸润性非特殊型癌的有14例,诊断为非浸润性癌的有7例,诊断为浸润性特殊型癌的有4例;应用保乳法治疗的患者有17例,应用肿瘤根除手术法的患者有4例,应用改良的肿瘤根除手术的患者有4例;19例患者无复发,另有5例患者复发,还有1例患者最终死亡。经治疗,患者的生存和生活质量较治疗前有明显提高,差异有统计学意义(P<0.05)。结论:病理诊断在乳腺癌手术治疗手段和保乳治疗法中占据着重要地位,能够为外科医生提供可靠地决策依据,在临床上极具应用价值。
Objective: To explore the value of pathological diagnosis in the selection and application of breast-conserving therapy for breast cancer. Methods: The clinical data of 25 patients undergoing surgery for breast cancer from June 2012 to June 2013 were retrospectively analyzed. The specific operation methods of breast-conserving surgery were analyzed, and the application value of pathological diagnosis was summarized. RESULTS: Of the 25 breast cancer patients, 14 were pathologically diagnosed as invasive nonspecific carcinomas, 7 were diagnosed as non-invasive carcinomas, and 4 were diagnosed as invasive special carcinomas. The breast-conserving method There were 17 treated patients, 4 treated with tumor eradication surgery, 4 with modified tumor eradication surgery, 19 without recurrence, 5 with recurrent disease, and 1 with final death . After treatment, the quality of life and quality of life of patients were significantly improved compared with those before treatment, the difference was statistically significant (P <0.05). Conclusion: Pathological diagnosis occupies an important position in the surgical treatment of breast cancer and breast-conserving therapy, which can provide reliable decision-making basis to surgeons and is clinically valuable.